Your Health, We Care
Release date: 2024-07-10 11:21:25 Recommended: 239
Crizotinib is suitable for the treatment of locally advanced or metastatic NSCLC with ALK positivity, as well as NSCLC diseases with ROS1 positivity. It is a tyrosine kinase inhibitor (TKI) that plays a therapeutic role in treating patients with advanced non-small cell lesions that are ALK positive and certain MET amplifications. Clozotinib inhibits the activity of certain specific tyrosine kinases, blocks cellular signaling pathways, and inhibits the growth and spread of diseased cells.
At a grand pharmaceutical exhibition held recently in Dubai, Lucius Company of L···【more】
Recommended：475Release date: 2024-07-09
On October 18-19, 2023, Dr. Luís Meirinhos Soares, a microbiology expert appoint···【more】
Recommended：474Release date: 2024-07-09
On October 19, 2023, the World Health Organization (WHO) conducted a comprehensi···【more】
Recommended：535Release date: 2024-07-09
At present, the competition in all walks of life is very fierce, especially in t···【more】
Recommended：413Release date: 2024-07-09
Here are some key points about Lucius Pharmaceutical:Lucius Pharmaceuticals has ···【more】
Recommended：612Release date: 2024-07-09
From the Black Sea, the most terrifying ocean on earth, to the Mediterranean Sea···【more】
Recommended：400Release date: 2024-07-09
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently mad···【more】
Recommended：569Release date: 2024-07-09
Lung cancer is the most rapidly increasing malignant tumor with the fastest incr···【more】
Recommended：481Release date: 2024-07-09
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the r···【more】
Recommended：261Release date: 2025-12-17
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved nirap···【more】
Recommended：266Release date: 2025-12-15
The U.S. Food and Drug Administration (FDA) announced today that it has approved···【more】
Recommended：276Release date: 2025-12-10
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisoca···【more】
Recommended：256Release date: 2025-12-08
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full ap···【more】
Recommended：301Release date: 2025-12-04
Primary analysis data from the randomized, double-blind, placebo-controlled phas···【more】
Recommended：260Release date: 2025-12-01
